FDA: Novartis knew of manipulation of data supporting Zolgensma approval - STAT

1. FDA: Novartis knew of manipulation of data supporting Zolgensma approval  STAT
2. Novartis Hid Manipulated Data While Seeking Approval for $2.1 Million Treatment  The New York Times
3. FDA Says Data Manipulated for Novartis Gene Therapy Drug  The Wall Street Journal
4. UPDATED: FDA opens probe into 'data manipulation' used to gain an FDA OK for a landmark Novartis gene therapy  Endpoints News
5. FDA: Drugmaker knew about 'manipulated data' before approval of the $2.1 million drug  USA TODAY
6. View full coverage on Google News